Bound to shock: Protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant

被引:20
作者
Sil, Diptesh [1 ]
Shrestha, Anurupa [1 ]
Kimbrell, Matthew R. [1 ]
Nguyen, Thuan B. [1 ]
Adisechan, Ashok K. [1 ]
Balakrishna, Rajalakshmi [1 ]
Abbo, Benjamin G. [1 ]
Malladi, Subbalakshmi [1 ]
Miller, Kelly A. [1 ]
Short, Shannon [1 ]
Cromer, Jens R. [1 ]
Arora, Shravan [1 ]
Datta, Apurba [1 ]
David, Sunil A. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66047 USA
关键词
D O I
10.1128/AAC.00200-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Lipopollysaccharide (LPS), or endotoxin, a structural component of gram-negative bacterial outer membranes, plays a key role in the pathogenesis of septic shock, a syndrome of severe systemic inflammation which leads to multiple-system organ failure. Despite advances in antimicrobial chemotherapy, sepsis continues to be the commonest cause of death in the critically ill patient. This is attributable to the lack of therapeutic options that aim at limiting the exposure to the toxin and the prevention of subsequent downstream inflammatory processes. Polymyxin B (PMB), a peptide antibiotic, is a prototype small molecule that binds and neutralizes LPS toxicity. However, the antibiotic is too toxic for systemic use as an LPS sequestrant. Based on a nuclear magnetic resonance-derived model of polymyxin B-LPS complex, we had earlier identified the pharmacophore necessary for optimal recognition and neutralization of the toxin. Iterative cycles of pharmacophore-based ligand design and evaluation have yielded a synthetically easily accessible N(1),mono-alkyl-mono-homologated spermine derivative, DS-96. We have found that DS-96 binds LPS and neutralizes its toxicity with a potency indistinguishable from that of PMB in a wide range of in vitro assays, affords complete protection in a murine model of LPS-induced lethality, and is apparently nontoxic in vertebrate animal models.
引用
收藏
页码:2811 / 2819
页数:9
相关论文
共 47 条
[1]   The three-dimensional structure of human bactericidal permeability-increasing protein - Implications for understanding protein-lipopolysaccharide interactions [J].
Beamer, LJ ;
Carroll, SF ;
Eisenberg, D .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (03) :225-229
[2]  
Bhattacharjya S, 1997, BIOPOLYMERS, V41, P251, DOI 10.1002/(SICI)1097-0282(199703)41:3<251::AID-BIP2>3.0.CO
[3]  
2-R
[4]   The sepsis syndrome - Definition and general approach to management [J].
Bone, RC .
CLINICS IN CHEST MEDICINE, 1996, 17 (02) :175-&
[5]   Structure-activity relationships in lipopolysaccharide neutralizers: Design, synthesis, and biological evaluation of a 540-membered amphipathic bisamide library [J].
Burns, MR ;
Jenkins, SA ;
Wood, SJ ;
Miller, K ;
David, SA .
JOURNAL OF COMBINATORIAL CHEMISTRY, 2006, 8 (01) :32-43
[6]   Lysine-spermine conjugates: hydrophobic polyamine amides as potent lipopolysaccharide sequestrants [J].
Burns, MR ;
Wood, SJ ;
Miller, KA ;
Nguyen, T ;
Cromer, JR ;
David, SA .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (07) :2523-2536
[7]  
Cavaillon JM, 2007, CONTRIB NEPHROL, V156, P101
[8]   Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry, allergies vs. non-allergies [J].
Cook, EB ;
Stahl, JL ;
Lowe, L ;
Chen, R ;
Morgan, E ;
Wilson, J ;
Varro, R ;
Chan, A ;
Graziano, FM ;
Barney, NP .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 254 (1-2) :109-118
[9]  
DAVID SA, 1995, J ENDOTOXIN RES, V2, P325
[10]   Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules [J].
David, SA .
JOURNAL OF MOLECULAR RECOGNITION, 2001, 14 (06) :370-387